Cargando…

Screening tools for early neuropsychological impairment after aneurysmal subarachnoid hemorrhage

BACKGROUND: Although most aneurysmal subarachnoid hemorrhage (aSAH) patients suffer from neuropsychological disabilities, outcome estimation is commonly based only on functional disability scales such as the modified Rankin Scale (mRS). Moreover, early neuropsychological screening tools are not used...

Descripción completa

Detalles Bibliográficos
Autores principales: Rautalin, Ilari M., Sebök, Martina, Germans, Menno R., Korja, Miikka, Dannecker, Noemi, Zindel-Geisseler, Olivia, Brugger, Peter, Regli, Luca, Stienen, Martin N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160061/
https://www.ncbi.nlm.nih.gov/pubmed/31802342
http://dx.doi.org/10.1007/s10072-019-04159-w
_version_ 1783522682148487168
author Rautalin, Ilari M.
Sebök, Martina
Germans, Menno R.
Korja, Miikka
Dannecker, Noemi
Zindel-Geisseler, Olivia
Brugger, Peter
Regli, Luca
Stienen, Martin N.
author_facet Rautalin, Ilari M.
Sebök, Martina
Germans, Menno R.
Korja, Miikka
Dannecker, Noemi
Zindel-Geisseler, Olivia
Brugger, Peter
Regli, Luca
Stienen, Martin N.
author_sort Rautalin, Ilari M.
collection PubMed
description BACKGROUND: Although most aneurysmal subarachnoid hemorrhage (aSAH) patients suffer from neuropsychological disabilities, outcome estimation is commonly based only on functional disability scales such as the modified Rankin Scale (mRS). Moreover, early neuropsychological screening tools are not used routinely. OBJECTIVE: To study whether two simple neuropsychological screening tools identify neuropsychological deficits (NPDs), among aSAH patients categorized with favorable outcome (mRS 0—2) at discharge. METHODS: We reviewed 170 consecutive aSAH patients that were registered in a prospective institutional database. We included all patients graded by the mRS at discharge, and who had additionally been evaluated by a neuropsychologist and/or occupational therapist using the Montreal Cognitive Assessment (MoCA) and/or Rapid Evaluation of Cognitive Function (ERFC). The proportion of patients with scores indicative of NPDs in each test were reported, and spearman correlation tests calculated the coefficients between the both neuropsychological test results and the mRS. RESULTS: Of the 42 patients (24.7%) that were evaluated by at least one neuropsychological test, 34 (81.0%) were rated mRS 0—2 at discharge. Among these 34 patients, NPDs were identified in 14 (53.9%) according to the MoCA and 8 (66.7%) according to the ERFC. The mRS score was not correlated with the performance in the MoCA or ERFC. CONCLUSION: The two screening tools implemented here frequently identified NPDs among aSAH patients that were categorized with favorable outcome according to the mRS. Our results suggest that MoCA or ERFC could be used to screen early NPDs in favorable outcome patients, who in turn might benefit from early neuropsychological rehabilitation.
format Online
Article
Text
id pubmed-7160061
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-71600612020-04-23 Screening tools for early neuropsychological impairment after aneurysmal subarachnoid hemorrhage Rautalin, Ilari M. Sebök, Martina Germans, Menno R. Korja, Miikka Dannecker, Noemi Zindel-Geisseler, Olivia Brugger, Peter Regli, Luca Stienen, Martin N. Neurol Sci Original Article BACKGROUND: Although most aneurysmal subarachnoid hemorrhage (aSAH) patients suffer from neuropsychological disabilities, outcome estimation is commonly based only on functional disability scales such as the modified Rankin Scale (mRS). Moreover, early neuropsychological screening tools are not used routinely. OBJECTIVE: To study whether two simple neuropsychological screening tools identify neuropsychological deficits (NPDs), among aSAH patients categorized with favorable outcome (mRS 0—2) at discharge. METHODS: We reviewed 170 consecutive aSAH patients that were registered in a prospective institutional database. We included all patients graded by the mRS at discharge, and who had additionally been evaluated by a neuropsychologist and/or occupational therapist using the Montreal Cognitive Assessment (MoCA) and/or Rapid Evaluation of Cognitive Function (ERFC). The proportion of patients with scores indicative of NPDs in each test were reported, and spearman correlation tests calculated the coefficients between the both neuropsychological test results and the mRS. RESULTS: Of the 42 patients (24.7%) that were evaluated by at least one neuropsychological test, 34 (81.0%) were rated mRS 0—2 at discharge. Among these 34 patients, NPDs were identified in 14 (53.9%) according to the MoCA and 8 (66.7%) according to the ERFC. The mRS score was not correlated with the performance in the MoCA or ERFC. CONCLUSION: The two screening tools implemented here frequently identified NPDs among aSAH patients that were categorized with favorable outcome according to the mRS. Our results suggest that MoCA or ERFC could be used to screen early NPDs in favorable outcome patients, who in turn might benefit from early neuropsychological rehabilitation. Springer International Publishing 2019-12-04 2020 /pmc/articles/PMC7160061/ /pubmed/31802342 http://dx.doi.org/10.1007/s10072-019-04159-w Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Rautalin, Ilari M.
Sebök, Martina
Germans, Menno R.
Korja, Miikka
Dannecker, Noemi
Zindel-Geisseler, Olivia
Brugger, Peter
Regli, Luca
Stienen, Martin N.
Screening tools for early neuropsychological impairment after aneurysmal subarachnoid hemorrhage
title Screening tools for early neuropsychological impairment after aneurysmal subarachnoid hemorrhage
title_full Screening tools for early neuropsychological impairment after aneurysmal subarachnoid hemorrhage
title_fullStr Screening tools for early neuropsychological impairment after aneurysmal subarachnoid hemorrhage
title_full_unstemmed Screening tools for early neuropsychological impairment after aneurysmal subarachnoid hemorrhage
title_short Screening tools for early neuropsychological impairment after aneurysmal subarachnoid hemorrhage
title_sort screening tools for early neuropsychological impairment after aneurysmal subarachnoid hemorrhage
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160061/
https://www.ncbi.nlm.nih.gov/pubmed/31802342
http://dx.doi.org/10.1007/s10072-019-04159-w
work_keys_str_mv AT rautalinilarim screeningtoolsforearlyneuropsychologicalimpairmentafteraneurysmalsubarachnoidhemorrhage
AT sebokmartina screeningtoolsforearlyneuropsychologicalimpairmentafteraneurysmalsubarachnoidhemorrhage
AT germansmennor screeningtoolsforearlyneuropsychologicalimpairmentafteraneurysmalsubarachnoidhemorrhage
AT korjamiikka screeningtoolsforearlyneuropsychologicalimpairmentafteraneurysmalsubarachnoidhemorrhage
AT danneckernoemi screeningtoolsforearlyneuropsychologicalimpairmentafteraneurysmalsubarachnoidhemorrhage
AT zindelgeisselerolivia screeningtoolsforearlyneuropsychologicalimpairmentafteraneurysmalsubarachnoidhemorrhage
AT bruggerpeter screeningtoolsforearlyneuropsychologicalimpairmentafteraneurysmalsubarachnoidhemorrhage
AT regliluca screeningtoolsforearlyneuropsychologicalimpairmentafteraneurysmalsubarachnoidhemorrhage
AT stienenmartinn screeningtoolsforearlyneuropsychologicalimpairmentafteraneurysmalsubarachnoidhemorrhage